GlassScriptPhysician profile
Anna M Bayes
NPI 1548379175
$7,185.28
in general payments reported to CMS, 2019-2025
40 companies · $1,863 in 2025
The $1,863 reported for 2025 was more than what 94% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,305 · 2022: $1,336 · 2023: $1,069 · 2024: $1,613 · 2025: $1,863.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,400 · Education: $145.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,399.67 |
| Education | $144.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,888.70 | 2021-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $717.58 | 2021-2025 | Fasenra, Breztri, Airsupra |
| Actelion Pharmaceuticals US, INC. | $700.19 | 2021-2023 | Uptravi |
| Grifols USA, LLC | $445.69 | 2022-2025 | Prolastin-C Liquid, Xembify |
| Novartis Pharmaceuticals Corporation | $432.79 | 2021-2024 | |
| Supernus Pharmaceuticals, INC. | $406.29 | 2024-2025 | Qelbree |
| Genzyme Corporation | $396.67 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $283.92 | 2023-2025 | Dupixent |
| Inspire Medical Systems, INC. | $280.56 | 2023-2025 | Inspire |
| Verona Pharma, INC. | $216.29 | 2025 | Ohtuvayre |
| Pulmonx Corporation | $146.76 | 2022 | |
| Novo Nordisk INC | $117.90 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Janssen Pharmaceuticals, INC | $97.70 | 2021-2022 | |
| Baxter Healthcare | $86.66 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Philips North America LLC | $84.05 | 2022-2025 | Vest Therapy Und |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Bayes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.